MYC

MYC Full Name

v-myc avian myelocytomatosis viral oncogene homolog

MYC Introduction

MYC, or v-myc avian myelocytomatosis viral oncogene homolog, encodes a multifunctional nuclear phosphoprotein that acts as a pivotal transcription factor controlling a wide range of cellular processes such as cell cycle progression, growth, apoptosis, and metabolism. Located on human chromosome 8q24.21, the MYC gene product (commonly referred to as c-Myc) forms a heterodimer with its partner MAX and binds to specific DNA sequences (E-box motifs) to regulate the transcription of numerous target genes that are central to cellular proliferation and differentiation. MYC was originally identified based on its homology to the viral v-myc oncogene, which drives transformation in avian myelocytomatosis viruses, and this evolutionary relationship underscores its fundamental role in growth regulation across species. In normal physiology, MYC expression is tightly controlled and transiently induced by mitogenic signals, but when dysregulated, it contributes to uncontrolled cellular proliferation.

Figure 1. Myc Regulates Cell Growth and Proliferation.(Sources: Dang CV,2012)

Functionally, MYC acts as a master regulator of gene expression that influences not only proliferative capacity but also metabolic reprogramming, ribosome biogenesis, protein synthesis, and cellular stress responses. By amplifying transcription at active promoters and coordinating the expression of genes involved in the cell cycle and growth, MYC ensures that cells can appropriately respond to external growth cues; however, aberrant MYC activity can shift this balance towards pathological states. In addition to driving proliferation, MYC modulates apoptosis and can either promote or inhibit programmed cell death depending on context and interacting partners, further illustrating its complex role in maintaining cellular homeostasis. Due to its broad regulatory influence across diverse pathways, research reagents such as MYC reporter kits, antibodies, and pathway modulators are widely employed in studies aimed at deciphering MYC biology, assay development, and drug discovery for diseases where MYC is implicated.

Clinically, dysregulation of MYC is one of the most common oncogenic events in human cancer, with amplification, overexpression, translocation, and other alterations observed in a large proportion of tumors including Burkitt lymphoma, diffuse large B-cell lymphoma, breast cancer, colorectal cancer, lung cancer, and many others. Such alterations disrupt normal growth control mechanisms, enhancing proliferation, metabolic reprogramming, genomic instability, and immune evasion, and are often associated with aggressive disease and poor prognosis. MYC's central oncogenic role has made it a focus for biomarker research and therapeutic targeting, and products targeting MYC at the protein or pathway level are integral to both basic cancer research and translational efforts to develop MYC-directed diagnostics and treatments.

Alternate Names for MYC

MYC; v-myc avian myelocytomatosis viral oncogene homolog; MRTL; MYCC; c-Myc; bHLHe39; myc proto-oncogene protein; proto-oncogene c-Myc; transcription factor p64; class E basic helix-loop-helix protein 39

• 1. Dang CV. MYC on the path to cancer. Cell. 2012, 149(1):22-35.